With a revenue increase of 60.85% in the first quarter 2026, year on year to cumulative value of $1,105 million, Apellis Pharmaceuticals Inc 's revenue per employee grew on a trailing twelve months basis to $ 1,495,643, this marks a new company high.
Within the Healthcare sector Employees of 36 other companies have achieved higher revenue per employee. While revenue per employee remained unchanged compared to the previous quarter at no. 403.Apellis Pharmaceuticals Inc has 739 employees.

What is Sales per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Revenue per Employee▼

None ▼

Revenue per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

APLS Revenue per Employee	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Revenue Change	60.85 %	-5.94 %	132.98 %	-10.61 %	-3.21 %
Sales per Employee (TTM) $	1,495,643	1,358,298	1,375,367	1,021,175	1,049,850
APLS's Total Ranking	# 403	# 403	# 249	# 668	# 459
Seq. Revenue Change	34.21 %	-56.41 %	156.92 %	7.01 %	-21.52 %

APLS Company Profile >> Back to APLS Efficiency Comparisons >> Compare APLS Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 22
Healthcare Sector	# 37
Overall Market	# 403

Revenue per Employee Statistics
High	Average	Low
$ 1,495,643	$ 687,044	$ 102,060
(Mar 31 2026)		(Dec 31 2022)

Financial Statements
Apellis Pharmaceuticals Inc 's Revenue MRQ	$ 268 Millions	Visit APLS's Income Statement
Apellis Pharmaceuticals Inc 's Revenues TTM	$ 1,105 Millions	Visit APLS's aggregate revenue growth
What are APLS's Sales?		Visit APLS's Sales by Segment

Other Ratios
Apellis Pharmaceuticals Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
APLS's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for APLS's Competitors
Revenue per Employee for APLS's Suppliers
Revenue per Employee for APLS's Customers

You may also want to know
APLS's Sales Growth Rates	APLS's Pe Price to earnings ratio	APLS's Receivables Turnover Ratio	APLS's Stock Quote
APLS's Net Income Growth Rates	APLS's Ps Price to Sales ratio	APLS's Sales per Employee	APLS's Asset Turnover Ratio
APLS's Net Margin	APLS's Pb Price to Book ratio	APLS's Financial Strength Ratios	APLS's Dividend Payout Ratio

Date modified: 2026-08-30T14:57:51+00:00

Companies with similar Revenue per Employee for 12 months ending Mar 31 2026, within Healthcare Sector	Revenue per Employee	Revenue 12 months ending Mar 31 2026	Number of Employees Mar 31 2026
Sarepta Therapeutics Inc	2,615,789.22	$ 2,184.184 Million	835
Innoviva Inc	2,479,150.94	$ 394.185 Million	159
Spero Therapeutics Inc	2,447,440.00	$ 61.186 Million	25
Aurinia Pharmaceuticals Inc	2,330,429.69	$ 298.295 Million	128
United Therapeutics Corporation	2,264,142.86	$ 3,169.800 Million	1,400
Elite Pharmaceuticals Inc	2,261,542.74	$ 147.000 Million	65
Anaptysbio Inc	2,234,500.00	$ 232.388 Million	104
Exelixis Inc	2,071,047.08	$ 2,375.491 Million	1,147
Kiniksa Pharmaceuticals International Plc	2,060,232.24	$ 754.045 Million	366
Cormedix Inc	2,040,572.14	$ 389.749 Million	191
Biocryst Pharmaceuticals Inc	2,036,128.74	$ 885.716 Million	435
Eton Pharmaceuticals Inc	1,968,500.00	$ 86.614 Million	44
Assertio Holdings inc	1,927,509.43	$ 102.158 Million	53
Siga Technologies Inc	1,913,809.53	$ 93.777 Million	49
Prestige Consumer Healthcare Inc	1,909,785.96	$ 1,088.578 Million	570
Zevra Therapeutics Inc	1,886,442.62	$ 115.073 Million	61
Incyte Corporation	1,885,028.13	$ 5,361.020 Million	2,844
Privia Health Group Inc	1,832,456.77	$ 2,246.592 Million	1,226
Tg Therapeutics Inc	1,755,260.65	$ 700.349 Million	399
Gilead Sciences Inc	1,749,176.47	$ 29,736.000 Million	17,000
Collegium Pharmaceutical Inc	1,747,635.93	$ 739.250 Million	423
Rigel Pharmaceuticals Inc	1,722,798.85	$ 299.767 Million	174
Alnylam Pharmaceuticals Inc	1,714,769.20	$ 4,286.923 Million	2,500
Atara Biotherapeutics Inc	1,681,428.57	$ 23.540 Million	14
Xenetic Biosciences Inc	1,595,036.50	$ 3.190 Million	2
Tarsus Pharmaceuticals Inc	1,593,570.27	$ 589.621 Million	370
Soleno Therapeutics Inc	1,565,978.02	$ 285.008 Million	182
Neurocrine Biosciences Inc	1,551,200.00	$ 3,102.400 Million	2,000
Jazz Pharmaceuticals Plc	1,535,863.32	$ 4,438.645 Million	2,890
Mirum Pharmaceuticals Inc	1,531,206.99	$ 569.609 Million	372

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.